pre feasibility reportenvironmentclearance.nic.in/writereaddata/online/tor/31_may_2017... · 1.1...

21
1 PRE FEASIBILITY REPORT FOR PROPOSED BULK DRUGS AND BULK DRUG INTERMEDIATES MANUFACTURING UNIT Of M/S. OSWAL UDHYOG Plot No. 8006, GIDC Estate, Ankleshwar-393002, Dist: Bharuch, Gujarat

Upload: others

Post on 13-Aug-2020

7 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

1

PRE FEASIBILITY REPORT

FOR

PROPOSED BULK DRUGS AND BULK DRUG

INTERMEDIATES MANUFACTURING UNIT

Of

M/S. OSWAL UDHYOG

Plot No. 8006, GIDC Estate,

Ankleshwar-393002,

Dist: Bharuch, Gujarat

Page 2: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

2

CONTENTS

Sr.

No.

Description Page No.

1. Executive Summary 3

2. Introduction of the Project/Background information 14

3. Project Description 15

4. Site Analysis 16

5. Planning Brief 19

6. Proposed Infrastructure 19

7. Rehabilitation and resettlement (R & R) Plan 20

8. Project Schedule & Cost Estimates 20

9. Analysis of Proposal (Final Recommendations) 21

Page 3: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

3

1.0 EXECUTIVE SUMMARY

1.1 Company Profile

Introduction

M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates manufacturing unit at

Plot No. 8006, GIDC Estate, Ankleshwar-393002, Tal: Ankleshwar, Dist: Bharuch, Gujarat.

Proposed project cost will be Rs. 2 Crores .

1.2 Project Details LIST OF PRODUCTS

Sr.

No.

NAME OF PRODUCTS CAS No. PROPOSED

Quantity

(MT/Month)

Bulk Drugs

1. Metoclopramide Hydrochloride 7232-21-5

5

2. Cetrizine Hydrochloride 83881-51-0

3. Ondensetron Hydrochloride 103639-04-9

4. Trifluoperazine Hydrochloride 440-17-5

5. Mebendazole 31431-39-7

6. Tolperison Hydrochloride 3644-61-9

7. Loratidine 79794-75-5

8. Fenofibrate and its intermediate 42019-78-3

9. Telmisartan and its intermediate 144701-48-4

10. Nebivilol and its intermediate 99199-60-7

11. Atorvastatin 134523-00-5

12. Phenylephrine HCl 61-76-7

13. Ambroxol 23828-92-4

14. Diclofenac Sodium 15307-79-6

15. Ofloxacin 82419-36-1

Sub ‐Total 5

Bulk Drug Intermediates

16. 3‐4 Diamino Benzophenone 39070-63-8

3.5

17. Acetyl Para amino Salicylic Acid 50-86-2

18.

4‐Acetamido, 2‐Methoxy, Benzoic

Acid Methyl Ester

4093-29-2

19. 5‐Chloro, 4‐Acetamido 2, Methoxy Benzoic Acid Methyl Ester

4093-31-6

20. 4‐Chloro Benzhydryl Chloride 134-83-8

21. 4‐Chloro Benzhydryl Piperazine 303-26-4

22. Cetrizine Base 83881-52-1

Sub ‐Total 3.5

Page 4: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

4

Grand ‐Total 8.5

By‐Products:

Sr.

No.

NAME OF PRODUCTS CAS No. PROPOSED

Quantity

(MT/Month)

1. Sodium Sulphite (25%) 7757-83-7 26.2

2. Piperazine ML (22%) 25332-39-2 4.0

3. AlCl3 7446-70-0 5.5

LIST OF RAW MATERIALS

Product Raw Material MT/MT

Metoclopramide Hydrochloride Potassium Hydroxide (KOH) 0.51

Meta Aminophenol (MAP) 0.91

Carbon Dioxide (CO2) Gas 0.37

Acetic Anhydride 1.12

Hydrochloric Acid (HCl) 1.44

Acetone 0.04

Potassium Carbonate (K2CO3) 0.91

Di Methyl Sulphate (DMS) 0.74

Acetic Acid 1.91

Chlorine (Cl2) Gas 0.3

Toluene 0.88

N, N – Di Ethyl Ethylene Di Amine (NND) 0.44

Hydrochloric Acid (HCl) (30%) 0.88

Soda Ash 0.23

Iso Propylalcohol 0.09

Sodium Hydroxide (NaOH) Flakes 0.3

Cetrizine Hydrochloride Methanol 0.72

Sodium Borohydride 0.07

p – Chloro Benzophenone (PCBP) 0.91

Benzene 0.12

Thionyl Chloride (TC) 0.55

Piperazine 0.36

Sodium Hydroxide (NaOH) 0.7

Toluene 0.09

2 – Chloro Ethanol (2‐CE) + 0.81

Tri Ethyl Amine (TEA)

Methylene Dichloride (MDC) 0.46

Potassium Hydroxide (KOH) 0.24

Page 5: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

5

Sodium Monochloro Acetate (SMCA) 0.49

Dimethyl Form amide (DMF) 0.02

Hydrochloric Acid Gas (HCl) 0.31

Acetone 0.41

Ondensetron Hydrochloride Ondensetron Base 0.91

Iso Propyl Alcohol (IPA) 3.54

Sodium Hydroxide (NaOH) 0.05

HCl 35% 0.21

Trifluoperazine Hydrochloride

1 ,Bromo, 3 – Chloro Propane (BCP) 0.50

N-Methyl Piperazine (NMP) 0.32

Toluene 0.47

Sodium Hydroxide (NaOH) 0.21

2, Trifluro Methyl Phenol Thiazine (TPZ) 0.83

Caustic Potash 0.18

Hydrochloric Acid Gas (HCl) 0.15

Methyl Iso Butyl Ketone ( MIBK) 0.09

Mebendazole Nitro Chloro Benzoic Acid (NCBA) 0.76

Thionyl Chloride (TC) 0.47

Benzene 1.47

Aluminium Chloride Anhydrous (AlCl3) 0.82

Liquid Ammonia (NH3) 2.59

Polysulphide 0.44

Methanol 0.47

Di Methyl Sulphite 0.82

Methyl Chloro Formate (MCF) 0.62

Sodium Hydroxide (NaOH) Lye 1.32

3 ,4 Di Amino Benzo Phenone (DABP) 0.88

Acetic Acid 0.38

Thiourea 0.71

Tolpersone Hydrochloride Piperidine 0.36

IPA 0.03

HCl 0.41

4,Me-Propiophenone 0.64

Paraformaldehyde 0.19

Acetone 0.3

Methanol 0.44

Charcoal 0.01

Hyflow 0.1

3 – 4, Diamino Benzophenone Nitro Chloro Benzo Phenone (NCBP) 0.87

Thionyl Chloride (TC) 0.53

Benzene 1.67

Aluminium Chloride Anhydrous (AlCl3) 0.93

Page 6: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

6

Liquid Ammonia (NH3) 2.93

Polysulphide 0.50

Methanol 0.53

Loratadine M-5 2.9

Sulphuric Acid 0.9

NaOH 3.25

MDC 3.22

SOCl2 3.32

DMF 0.14

AlCl3 0.73

Hyflow 0.63

Ethylene Dibromide 0.24

THF 0.58

Iodine 0.01

HCl 1.55

Chloroform 1.40

Hexane 2.25

Toluene 0.61

NaHCO3 1.68

Acetonitrile 0.16

Fenofibrate and its intermediate 4-CHBP 1

Acetone 0.36

Caustic soda 1.28

Chloroform 1.26

H2SO4 1.52

Activated charcoal 0.11

Sodium bicarbonate 1.2

IPA 17.15

Sodium bicarbonate 0.63

Hyflow 0.02

MDC 0.07

IPA 3

Telmisartan and its intermediate Methanol 3.53

4-Amino 3-Methylbenzoic acid 1.48

Conc. Sulphuric Acid 1.42

Liq. NH3 2.97

MDC 5.67

TEA 1.31

Butyl Chloride 1.29

Sodium Bicarbonate 0.24

Hexane 5.09

Fuming Nitric Acid 4.05

Page 7: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

7

Nebivilol and its intermediate

Maleic Anhydride 1.4

AlCl3 3.87

EDC 3.04

Para Fluoro Anisole 1.46

HCl 3.32

Hexane 2.67

Acetic Acid 0.85

Sulphuric Acid 1.18

Pd/c 0.41

Hyflow 0.82

Sodium Borohydride 1.16

THF 1.76

MDC 3.49

Sodium Carbonate 0.89

DMSO 0.55

Oxahl Chloride 3.27

TEA 6.49

Sodium Hydride 0.98

Methanol 18.03

Benzyl Amine 0.33

Acetonitrile 8.16

Atorvastatin Ethyl-4,Cyano3-hydroxy Butanol 0.54

THF 0.28

Diisopropyl amine 0.66

N-Butyl Lithium 0.37

Tert-Butyl acetate 0.91

HCl 0.41

Ethyl Acetate 0.34

NaCl 0.65

Methanol 0.34

DEMB (50 % Soln) 0.38

Sodium Borohydride 0.24

Acetic Acid 0.53

Dimethoxy Propane 0.98

Methane Sulphonic Acid 0.02

Sodium Bicarbonate 1.08

n-Hexane 0.04

Raney Nickel 0.54

Pivalic Acid 0.13

Toluene 0.10

Activated Carbon 0.05

Methyl Tert Butyl 0.20

Page 8: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

8

Phenylephrine HCl

3 Hydroxy Acetophenone 1.80

Ethyl Acetate 0.13

Bromine 0.78

Toluene 0.56

Sodium Bi Carbonate Solution 0.18

2-Methyl Benzyl Amine 2.92

IPA HCl 1.44

Methanol 0.56

Palladium Charcoal Catalyst 0.28

Carbon 0.05

Liq. Ammonia 4.87

IPA 0.13

L(+)Tartaric Acid 1.36

Acetic Anhydride 1.80

Sulphuric Acid 0.37

IPA HCl 20% 0.8

Carbon 0.04

Acetone 0.06

Ambroxol Methanol 0.17

Methyl anthranilate 0.54

Bromine 0.63

Liq. Ammonia 0.15

Hydrogen peroxide 0.20

THF 0.12

Sodium Boro hydride 0.22

Acetic acid 0.02

Toluene 0.39

Charcoal 0.04

Manganese dioxide 1.93

Trans 4-amino Cyclohexanol 0.29

IPA 0.16

Act carbon 0.01

HCl 0.24

Diclofenac Sodium 2,6 Dichloro phenol 0.65

Toluene 0.91

Potassium carbonate 0.35

Mono Methyl Chloro Acetic Acid 0.48

Aniline 0.36

Sodium Methoxide Solution 0.71

Chloro Acetyl Chloride 0.49

Ofloxacin Ofloxacin q acid 0.83

Methanol 0.83

Page 9: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

9

N‐methyl Piperazine 0.35

N‐Butanol 0.49

Activated carbon 0.03

Acetic acid 0.29

Liquor ammonia 0.28

3‐4 Diamino Benzophenone NCBA 0.99

Thionyl Chloride 0.61

Benzene 1.91

AlCl3 1.07

NCBP 1.45

Liq. NH3 3.36

NABP 1.34

Polysulphide 0.57 Methanol 0.61

Acetyl Para amino Salicylic

Acid KOH 0.49

MAP 0.87

CO2 Gas 0.36

Acetic Anhydride 1.07

HCl 1.09

4‐ Acetamido, 2‐ Methoxy, KOH 0.54

Benzoic Acid Methyl Ester MAP 0.97

CO2 Gas 0.40

Acetic Anhydride 1.19

HCl 1.21

Acetone 0.05

K2CO3 0.97

DMS 0.79

5‐ Chloro, 4‐ Acetamido 2, KOH 0.58

Methoxy Benzoic Acid Methyl MAP 1.03

Ester CO2 Gas 0.42

Acetic Anhydride 1.27

HCl 1.29

Acetone 0.05

K2CO3 1.03

DMS 0.84

Cl2 Gas 0.34

4‐Chloro Benzhydryl Chloride Methanol 0.21

Sodium Boro hydride 0.02

PCBP 0.26

Benzene 0.68

Thionyl Chloride 0.16

Page 10: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

10

4‐Chloro Benzhydryl Piperazine Methanol 0.72

Sodium Boro hydride 0.07

PCBP 0.91

Benzene 0.04

Thionyl Chloride 0.55

Piperazine 0.36

NaOH 0.70

Cetrizine Base Methanol 0.13 Sodium Boro hydride 0.01

PCBP 0.16

Benzene 0.43

Thionyl Chloride 0.10

Piperazine 0.06

NaOH 0.12

Toluene 0.42

2‐CE+TEA 0.15

MDC 0.86

KOH 0.04

SMCA 0.09

DMF 0.01

Acetone 0.90

1.3 Green Belt Development

Company will develop an effective green belt within the factory and on periphery of the

factory. In addition to this, majority of the vacant land shall be planted with trees, shrubs and

grasses.

1.4 Power & Fuel Requirement

Power required: Power Requirement: 250 KVA from DGVCL

D.G. Set: 150 KVA

Fuel Requirement:

Agro waste: 4 MT/Day

HSD: 20 Lit/Hr

1.5 Water Requirement and Wastewater Generation & Treatment

Source of water will be met through GIDC Water Supply. Total water requirement will be

19.6 KL/Day from GIDC. Total 8.2 KL/Day (6.6 KL/Day Industrial + 1.6 KL/Day Domestic)

of effluent shall be generated. 6.6 KL/Day industrial effluents will be treated in ETP

Page 11: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

11

consisting of primary treatment and then sent to CETP for further treatment & disposal.

Domestic wastewater (1.6 KL/Day) will be discharged into septic tank & soak pit.

1.6 Air Pollution Source and Control Management

The source of air pollution due to the project will be Flue gas emission& process emission.

Flue Gas Emission 1. Details of Flue Gas Stack; Stack Attached to Thermo pack Boiler

SOURCES OF GASESOUS EMISSIONS STACK

Capacity 3 Lack KCal /Hr

Fuel Used Agro waste: 1.5 MT/Day

Type of Emissions SO2 NOx SPM

Permissible Limits 262 mg/Nm3 94 mg/Nm

3 150 mg/Nm

3

Stack Height 30 meters

Stack Diameter at the Top 600 mm

APCM

Multicyclone Separator with bag

filter

2. Details of Flue Gas Stack; Stack Attached To Steam Boiler

SOURCES OF GASESOUS EMISSIONS STACK

Capacity 1.5 TPH

Fuel Used Agro waste: 2.5 MT/Day

Type of Emissions SO2 NOx SPM

Permissible Limits 262 mg/Nm3 94 mg/Nm

3 150 mg/Nm

3

Stack Height 30 meters

Stack Diameter at the Top 600 mm

APCM

Multicyclone Separator with bag

filter

3. Details of Flue Gas Stack; Stack Attached To D. G. Set

SOURCES OF GASESOUS

EMISSIONS STACK

Capacity D.G.Set: 150 KVA Fuel Used HSD: 20 Lit/Hr

Type of Emissions SO2 NOx SPM

Permissible Limits 262 mg/Nm3 94 mg/Nm

3 150 mg/Nm

3

Stack Height 11 meters

4. Details of Process Vent; Vent Attached To Process

Sr. Stack attached to Stack Air Pollution Parameter Permissible

No. Height Control System Limit

Proposed

Page 12: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

12

1 Process Vent 11 m

Two stage Alkali

+ Water scrubber

HCl 20 mg/Nm3

SO2 40 mg/Nm3

1.7 Hazardous Waste Management

Type of

Waste

Schedule Source Quantity Disposal Method

Category

ETP waste 34.3 ETP 1.0 MT/ Month Collection, Storage, Transportation &

Disposal to TSDF site

Used Oil 5.1 Plant & 0.05 KL/ Month Collection, Storage, Transportation &

Machinery sale to GPCB authorized recycler

Discarded

Containers/

Bags/ Carboys

33.3 Process Bags = 500 Nos. /

Month,

Drums = 100 Nos. /

Month

Collection, Storage, Transportation,

Decontamination & sale to registered

vendor.

Distillation 20.3 Process 1.0 MT/ Month Collection, Storage, Transportation &

Residue Disposal to Incinerator site or sent to

cement industries for co‐processing

Spent Catalyst ‐‐ Process 0.2 MT/Month Collection, Storage, Transportation &

Disposal to Incinerator site or return

to supplier

Spent Carbon ‐‐ Process 0.5 MT/Month Collection, Storage, Transportation &

Disposal to Incineration site or sent to

cement industries for co‐processing

Page 13: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

13

Storage Details of Hazardous Chemicals

Sr. Name of the Maximum Mode of Actual State & Possible type of

No Hazardous Storage Storage Storage Operating Hazards

Substance pressure &

temperature

1 Acetic Anhydride 2 MT Drum 200 Lit NTP Flammable/Toxic

2 HCl 10 MT Tank 10 MT x 1 NTP Corrosive

3 Acetone 1 MT Drum 200 Lit NTP Flammable/Toxic

4 Acetic Acid 1 MT Drum 200 Lit NTP Corrosive

5 Chlorine 1 MT Tonner 900 Kg 7 Kg/cm2 Toxic

and Ambient

Temp.

6 Toluene 1 MT Drum 5 MT x 1 NTP Flammable

7 Methanol 1 MT Drum 200 Lit NTP Flammable

8 2‐Chloro Ethanol 0.2 MT Drum 200 Lit NTP Flammable

9 Tri Ethyl Amine 0.2 MT Drum 200 Lit NTP Flammable

10 MDC 0.22 MT Drum 200 Lit NTP Toxic

11 IPA 0.3 MT Drum 200 Lit NTP Flammable

12

Liq. Ammonia

(25%) 0.6 MT Drum 200 Lit NTP Toxic

13 Benzene 0.6 MT Drum 200 Lit NTP Flammable

14 Thionyl Chloride 0.6 MT Drum 200 Lit NTP Corrosive

15 MDC 0.6 MT Drum 200 Lit NTP Toxic

16 DMF 0.6 MT Drum 200 Lit NTP Flammable

17 TEA 0.2 MT Drum 200 Lit NTP Flammable

18 n‐Hexane 0.2 MT Drum 200 Lit NTP Toxic

19 Ethyl Acetate 0.2 MT Drum 200 Lit NTP Flammable 20 Sulphuric Acid 10 MT Tank 10 MT x 1 NTP Corrosive

Page 14: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

14

2.0 INTRODUCTION OF THE PROJECT/BACKGROUND INFORMATION

2.1 Identification of the project and project proponent. In case of mining project, a copy

of mining lease/letter of intent should be given.

Identification of the project

Proposed bulk drugs and Bulk drug intermediates manufacturing unit.

Identification of the project proponent

Presently following is the Proprietor of the company:

1. Mrs. Mamtaben Dobaria

2.2 Brief description of nature of the Project

Proposed bulk drugs and Bulk drug intermediates manufacturing unit.

2.3 Need for the project and its importance to the country and or region

The objective is to be achieved by:

• Consolidating Business.

• By constantly upgrading the product range.

• Continuously reducing the Costs & improving Quality.

• To generate local employment.

2.4 Demands-Supply Gap

Based on our informal survey of the market with our current customers and various traders,

we have found that there is a big potential for the range of the products we are planning.

2.5 Imports vs. Indigenous production

Based on the current cost of indigenous raw materials and the non availability of some

materials, we will have to import some of the key raw materials as they are not available

indigenously. This will make us very competitive against imported finished products and we

will be able to increase the export of our finished products.

2.6 Export possibility

There is export potential of our proposed products.

2.7 Domestic/Export Markets There is export potential as well as demand in local market.

2.8 Employment Generation (Direct and Indirect) due to project.

Employment would be as per prevailing norms of state government for skilled and unskilled

people for the proposed project.

Page 15: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

15

3.0 Project Description

3.1 Type of Project including interlinked and interdependent projects, if any.

Proposed bulk drugs and Bulk drug intermediates manufacturing unit.

Category: A-5(f)

3.2 Location (map showing general location, specific location and project boundary &

project site layout) with coordinates.

Map showing general location

Page 16: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

16

Plant Layout

Page 17: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

17

3.3 Details of alternate sites considered and the basis of selecting the proposed site,

particularly the environmental considerations gone into should be highlighted. Major factors involved in the selection of site are listed below:

• Existing purchased plot.

• Site is very well connected by road

• Proximity to Raw Material suppliers

• Availability of sufficient land free from cultivation

• Availability of power evacuation facilities

• Availability of water for industrial use

Modern infrastructure support and amenities at par with industrial estates in other global

markets, including:

� Efficient transport facilities within the industrial estate and to & fro the city area.

� Environment-friendly zone.

� Uninterrupted power supply.

3.4 Size or Magnitude of Operation

Please refer Annexure-I of Form-I.

3.5 Project Description with process details (a schematic diagram/flow chart showing

the project layout, components of the project etc. should be given)

Please refer Annexure-III in Form-I.

3.6 Raw material required along with estimated quantity, likely source, marketing area

of final products. Mode of transport of raw materials and finished products.

Please refer Annexure-I in Form-I.

3.7 Resource optimization/recycling and reuse envisaged in the project, if any, should

be briefly outlined.

After set-up of unit, every effort will put to recycle/reuse the water.

3.8 Availability of water its source, energy/power requirement and source should be

given.

Water Source

Total water requirement shall be met through GIDC water supply.

Power required: Power Requirement: 250 KVA from DGVCL

D.G. Set: 150 KVA

Fuel Requirement:

Agro waste: 4 MT/Day

HSD: 20 Lit/Hr

Page 18: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

18

3.9 Quantity of wastes to be generated (liquid and solid) and scheme for their

management/disposal.

Please refer Annexure - V & VI.

3.10 Schematic representations of the feasibility drawing which give information of EIA

purpose.

RECONNAISSANCE SURVEY OF EXISTING PLANT ANNUAL REPORT

MARKET ASSESSMENT

FINANCIAL REPORT

PROJECT REPORT

INTRODUCTION

MONITORING OF AIR, WATER & SOIL QUALITY & NOISE

LEVELS. DATA ON METEOROLOGY SOCIO‐ECONOMIC

STATUS & BASIC AMENITIES. SITE VISITS BY AND

INTERVIEWS WITH LOCALS

BASELINE

ENVIRONMENTAL

STATUS

ENVIRONMENTAL INFORMATION CENTRE

CENTRAL GROUND WATER BOARD

GUJARAT POLLUTION CONTROL BOARD (GPCB)

PUBLIC HEALTH ENGINEERING DEPT.

AGRICULTURE DEPARTMENT

FOREST DEPARTMENT

IRRIGATION DEPARTMENT

EMPLOYMENT EXCHANGE

HEALTH CENTER

CENSUS DEPT.

INDIAN METEOROLOGICAL DEPT.

SOCIOECONOMIC

STATUS &

INFRASTRUCTURE

PROPOSED

EXPANSION PLANT

FACILITY DESCRIPTION

IMPACTS

METHODOLOGY OF

IMPACT

ASSESSMENT

IDENTIFICATION & ASSESSMENT OF IMPACTS

EVALUATION OF IMPACTS BY MATRIX METHOD

SOURCE OF INFORMATION OVERVIEW OF

E. I. A. STUDIES

ACTIVITIES

ENVIRONMENTAL

MANAGEMENT PLAN

DESCRIPTION OF EFFLUENT TREATMENT PLAN, AIR

POLLUTION CONTROL, HAZARDOUS WASTE

MANAGEMENT, GREEN BELT DEVELOPMENT

MONITORING PROGRAM

RISK ANALYSIS

STUDIES &

DISASTER

MANAGEMENT PLAN

SAFETY, HEALTH & ENVIRONMENTAL POLICY, GUIDELINES BY

DIRECTOR GENERAL OF FACTORY SAFETY, MINISTRY OF LABOR. CONSEQUENCE ANALYSIS

PREPARATION OF DISASTER MANAGEMENT PLAN

Page 19: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

19

4.0 Site Analysis

4.1 Connectivity

• Site is very well connected by road & rail

• Availability of power evacuation facilities

• Availability of water for industrial use

4.2 Land Form, Land Use and Land Ownership

It will be incorporated in EIA Studies.

4.3 Topography (along with map)

We will incorporate topography in EIA Studies.

4.4 Existing land use pattern (agriculture, non-agriculture, forest, water bodies

(including area under CRZ)), shortest distances from the periphery of the project to

periphery of the forests, national park, wild life sanctuary, eco sensitive areas, water

bodies (distance from HFL of the river), CRZ. In case of the notified industrial area, a

copy of the Gazette notification should be given.

It will be incorporated in EIA Studies. CRZ Clearance is not applicable.

4.5 Existing Infrastructure

This is proposed project activity so now there is only open land.

4.6 Soil Classification

It will be incorporated in EIA Studies.

4.7 Climatic data from secondary sources.

Primary source: our own weather station & Secondary Sources: Indian Meteorological

Department, Ahmadabad.

4.8 Social infrastructure available.

Depending on the growth of the company the required social infrastructure will be provided.

5.0 Planning Brief

5.1 Planning Concept (type of industries, facilities, transportation etc) Town and

Country planning/Development authority classification.

Type of Industry: Proposed project of bulk drugs and Bulk drug intermediates manufacturing

unit.

5.2 Population Projection

It will be incorporated in EIA Studies.

5.3 Land use planning (breakup along with green belt etc.)

It will be incorporated in EIA Study.

Page 20: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

20

5.4 Assessment of Infrastructure Demand (Physical & Social)

It will be incorporated in EIA Studies.

5.5 Amenities/Facilities

It will be incorporated in EIA Studies.

6.0 Proposed Infrastructure

6.1 Industrial Area (Processing Area)

Processing Area (plant area, ETP Area and Utility Area, Admin) = 4,000 m2

6.2 Residential Area (Non Processing Area)

Non Processing Area (Green belt, Raw material storage area, open/road area, Parking, Gate)

= 4,713.7 m2

6.3 Green Belt

Company will develop an effective green belt within the factory and on periphery of the

factory. In addition to this, majority of the vacant land shall be planted with trees, shrubs and

grasses.

6.4 Social Infrastructure

Depending on the growth of the company the required social infrastructure will be provided.

6.5 Connectivity (Traffic and Transportation Road/ Rail/Metro/ Water ways etc)

Site is very well connected by road & railway.

6.6 Drinking water Management (Source & Supply of water)

Water requirement will be met through GIDC water supply.

6.7 Sewerage System

Sewage pipes will be laid in entire company for the removal and disposal of mainly non-

harmful liquid wastes from the offices, canteen and domestic waste coming from different

sections. These liquid wastes will be treated and disposed by septic tank and soak pit.

6.8 Solid Waste Management

Please refer Section 1.7, Page No. 12 in Pre-Feasibility Report.

7.0 Rehabilitation and Resettlement (R & R) Plan

7.1 Policy to be adopted (central/state) in respect of the project affected including home

ousters, land ousters and landless laborers (a brief outline to be given)

Page 21: PRE FEASIBILITY REPORTenvironmentclearance.nic.in/writereaddata/Online/TOR/31_May_2017... · 1.1 Company Profile Introduction M/S. OSWAL UDHYOG proposes Bulk drugs & Bulk drug intermediates

21

There is no habitation on the proposed project area and it is open industrial land which is

purchased by company for development of Company, so that R & R policy is not applicable

to this project. There shall be no displacement of any population in project area.

8. Project Schedule & Cost Estimates

8.1 Likely date of start of construction and likely date of completion (Time schedule for

the project to be given).

We shall start construction after getting environmental clearance. We shall start production

upon making application for CCA.

8.2 Estimated Project cost along with analysis in terms of economic viability of the

project.

Total costs of the project will Rs. 2 Crores.

9. Analysis of Proposal (Final Recommendations)

9.1 Financial and social benefits with special emphasis on the benefit to be local people

including tribal population, if any, in the area.

• Employment would be as per prevailing norms of state government for skilled and

unskilled people for the proposed project.

• Social Welfare shall be done.

• Cordial relation with the industry shall be established and representation shall be made to

villagers for help for creation of facilities related to health, education, etc.